These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
319 related items for PubMed ID: 9482361
1. Corpus callosum atrophy is a possible indicator of region- and cell type-specific neuronal degeneration in Alzheimer disease: a magnetic resonance imaging analysis. Hampel H, Teipel SJ, Alexander GE, Horwitz B, Teichberg D, Schapiro MB, Rapoport SI. Arch Neurol; 1998 Feb; 55(2):193-8. PubMed ID: 9482361 [Abstract] [Full Text] [Related]
2. In vivo imaging of region and cell type specific neocortical neurodegeneration in Alzheimer's disease. Perspectives of MRI derived corpus callosum measurement for mapping disease progression and effects of therapy. Evidence from studies with MRI, EEG and PET. Hampel H, Teipel SJ, Alexander GE, Pogarell O, Rapoport SI, Möller HJ. J Neural Transm (Vienna); 2002 May; 109(5-6):837-55. PubMed ID: 12111472 [Abstract] [Full Text] [Related]
3. Region-specific corpus callosum atrophy correlates with the regional pattern of cortical glucose metabolism in Alzheimer disease. Teipel SJ, Hampel H, Pietrini P, Alexander GE, Horwitz B, Daley E, Möller HJ, Schapiro MB, Rapoport SI. Arch Neurol; 1999 Apr; 56(4):467-73. PubMed ID: 10199337 [Abstract] [Full Text] [Related]
4. Progression of corpus callosum atrophy in Alzheimer disease. Teipel SJ, Bayer W, Alexander GE, Zebuhr Y, Teichberg D, Kulic L, Schapiro MB, Möller HJ, Rapoport SI, Hampel H. Arch Neurol; 2002 Feb; 59(2):243-8. PubMed ID: 11843695 [Abstract] [Full Text] [Related]
6. Regional pattern of hippocampus and corpus callosum atrophy in Alzheimer's disease in relation to dementia severity: evidence for early neocortical degeneration. Teipel SJ, Bayer W, Alexander GE, Bokde AL, Zebuhr Y, Teichberg D, Müller-Spahn F, Schapiro MB, Möller HJ, Rapoport SI, Hampel H. Neurobiol Aging; 2003 Feb; 24(1):85-94. PubMed ID: 12493554 [Abstract] [Full Text] [Related]
7. Topography of callosal atrophy reflects distribution of regional cerebral volume reduction in Alzheimer's disease. Pantel J, Schröder J, Jauss M, Essig M, Minakaran R, Schönknecht P, Schneider G, Schad LR, Knopp MV. Psychiatry Res; 1999 Jun 30; 90(3):181-92. PubMed ID: 10466737 [Abstract] [Full Text] [Related]
8. Callosal circularity as an early marker for Alzheimer's disease. Van Schependom J, Niemantsverdriet E, Smeets D, Engelborghs S. Neuroimage Clin; 2018 Jun 30; 19():516-526. PubMed ID: 29984160 [Abstract] [Full Text] [Related]
9. Callosal atrophy in patients with lacunar infarction and extensive leukoaraiosis. An indicator of cognitive impairment. Yamauchi H, Fukuyama H, Ogawa M, Ouchi Y, Kimura J. Stroke; 1994 Sep 30; 25(9):1788-93. PubMed ID: 8073459 [Abstract] [Full Text] [Related]
10. [Alzheimer's disease and vascular dementia. Determination of atrophy of the corpus callosum and cerebral cortex]. Möller T, Born C, Reiser MF, Möller HJ, Hampel H, Teipel SJ. Nervenarzt; 2009 Jan 30; 80(1):54-61. PubMed ID: 18810380 [Abstract] [Full Text] [Related]
11. Callosal atrophy parallels decreased cortical oxygen metabolism and neuropsychological impairment in Alzheimer's disease. Yamauchi H, Fukuyama H, Harada K, Nabatame H, Ogawa M, Ouchi Y, Kimura J, Konishi J. Arch Neurol; 1993 Oct 30; 50(10):1070-4. PubMed ID: 8215966 [Abstract] [Full Text] [Related]
12. Corpus callosum atrophy and cognitive decline in early Alzheimer's disease: longitudinal MRI study. Zhu M, Wang X, Gao W, Shi C, Ge H, Shen H, Lin Z. Dement Geriatr Cogn Disord; 2014 Oct 30; 37(3-4):214-22. PubMed ID: 24193144 [Abstract] [Full Text] [Related]
13. Corpus callosum size correlates with asymmetric performance on a dichotic listening task in healthy aging but not in Alzheimer's disease. Gootjes L, Bouma A, Van Strien JW, Van Schijndel R, Barkhof F, Scheltens P. Neuropsychologia; 2006 Oct 30; 44(2):208-17. PubMed ID: 15955540 [Abstract] [Full Text] [Related]
14. Atrophy of the corpus callosum, cognitive impairment, and cortical hypometabolism in progressive supranuclear palsy. Yamauchi H, Fukuyama H, Nagahama Y, Katsumi Y, Dong Y, Konishi J, Kimura J. Ann Neurol; 1997 May 30; 41(5):606-14. PubMed ID: 9153522 [Abstract] [Full Text] [Related]
15. Corpus callosal atrophy and associations with cognitive impairment in Parkinson disease. Goldman JG, Bledsoe IO, Merkitch D, Dinh V, Bernard B, Stebbins GT. Neurology; 2017 Mar 28; 88(13):1265-1272. PubMed ID: 28235816 [Abstract] [Full Text] [Related]
16. Dissociation between corpus callosum atrophy and white matter pathology in Alzheimer's disease. Teipel SJ, Hampel H, Alexander GE, Schapiro MB, Horwitz B, Teichberg D, Daley E, Hippius H, Möller HJ, Rapoport SI. Neurology; 1998 Nov 28; 51(5):1381-5. PubMed ID: 9818864 [Abstract] [Full Text] [Related]
17. Atrophy of the corpus callosum, cortical hypometabolism, and cognitive impairment in corticobasal degeneration. Yamauchi H, Fukuyama H, Nagahama Y, Katsumi Y, Dong Y, Hayashi T, Konishi J, Kimura J. Arch Neurol; 1998 May 28; 55(5):609-14. PubMed ID: 9605717 [Abstract] [Full Text] [Related]
18. Corpus callosum in neurodegenerative diseases: findings in Parkinson's disease. Wiltshire K, Foster S, Kaye JA, Small BJ, Camicioli R. Dement Geriatr Cogn Disord; 2005 May 28; 20(6):345-51. PubMed ID: 16192724 [Abstract] [Full Text] [Related]
19. Atrophy of the corpus callosum associated with cognitive impairment and widespread cortical hypometabolism in carotid artery occlusive disease. Yamauchi H, Fukuyama H, Nagahama Y, Katsumi Y, Dong Y, Konishi J, Kimura J. Arch Neurol; 1996 Nov 28; 53(11):1103-9. PubMed ID: 8912483 [Abstract] [Full Text] [Related]
20. When, where, and how the corpus callosum changes in MCI and AD: a multimodal MRI study. Di Paola M, Di Iulio F, Cherubini A, Blundo C, Casini AR, Sancesario G, Passafiume D, Caltagirone C, Spalletta G. Neurology; 2010 Apr 06; 74(14):1136-42. PubMed ID: 20368633 [Abstract] [Full Text] [Related] Page: [Next] [New Search]